Oncology Research

KEY FINDING: Re-irradiation is an effective treatment for MSCC, with 81.8% of evaluable patients experiencing stable or improved mobility at 5 weeks post-treatment.

KEY FINDING: miR-491-3p acts as a tumor suppressor gene in RB, inhibiting the growth and metastasis of tumors by targeting SNN.

KEY FINDING: Patients with spinal cord compression caused by metastatic disease experienced significantly improved sleep quality after undergoing TES and PSRS treatments.

KEY FINDING: Preoperative embolization with n-BCA is a safe procedure for MSCC.

KEY FINDING: For 3D radiotherapy, cumulative doses from 55.2 Gy2/2 to 65.5 Gy2/2 EQD2 showed no cases of radiation-induced myelopathy.

KEY FINDING: Following tSCI, the immune response likely exerts both beneficial and harmful roles and as previously discussed both the innate and adaptive immune systems have been implicated in secondary injury progression in tSCI.

KEY FINDING: The proposed model achieved high segmentation accuracy with a Dice Similarity Coefficient (DSC) of 89.60 ± 3.56% and a Hausdorff distance of 1.49 ± 0.65 mm.

KEY FINDING: Carotid body tumors, while typically benign, can exhibit metastatic potential, even many years after initial diagnosis and treatment.

KEY FINDING: Less aggressive treatments for AVH, such as embolization and decompression with vertebroplasty, can be effective.

KEY FINDING: SCI leads to primary physical injury followed by secondary injury caused by inflammation, ischemia, oxidative stress, axonal degeneration and glial scar formation.